Privigen IVIg—safety and efficacy you can trust
Clinically proven protection against infections
Privigen helps strengthen the immune system with beneficial immunoglobulin G antibodies to prevent infections and protect the health of people who have PI.
Helping people overcome the effects of the PI for more than 13 years
Privigen was evaluated in 2 clinical trials: a 1-year study plus an extension that lasted 2½ years. While taking Privigen, study participants averaged less than one acute serious bacterial infection per year, such as pneumonia, bacteremia/septicemia, osteomyelitis/septic arthritis, bacterial meningitis, and visceral abscess.
In 1-year study
3.55
infections per
patient per year
0.08
acute serious bacterial
infections/year
In 2½-year study
1.60
infections per
patient per year
0.02
acute serious bacterial
infections/year
On average, the participants reported feeling "well."* In the clinical studies, participants recorded how they felt every day.
*Based on personal assessment, patients' overall feeling of well-being score was classified as "well" on a five-point scale (1 = very well, 2 = well, 3 = fair, 4 = poor, 5 = very poor), with a mean of 2.1 ± 0.8 standard deviation.
IVIg safety—PI studies showed tolerability with Privigen
Most of the side effects with Privigen were not serious, and most side effects were of mild or moderate intensity.†
1-year study
97%
of side effects
were not serious†
2½-year study
96%
of side effects
were not serious§
† Serious adverse reactions in the pivotal trial included hypersensitivity, chills, fatigue, dizziness, and increased body temperature (all severe), occurring in one subject and resulting in the subject’s withdrawal from the study. Two other subjects withdrew from the study due to adverse reactions of vomiting in one subject and chills and headache in the other. 11 patients had serious reactions in the extension trial.
‡ 90% were rated mild or moderate in severity.
§ 93% were rated mild or moderate in severity.
Most common|| Privigen side effects
- Headache
- Fatigue
- Nausea
- Fever
- High blood pressure
Serious side effects in the 1-year study all occurred in one subject, one of three who withdrew from the study due to adverse reactions. In the long-term study, one subject withdrew because of a mild case of hives.
These are not the only side effects possible; see the full prescribing information, including boxed warning, for a complete list of adverse reactions possible with treatment for each condition.
Call your doctor if you experience any side effects, or if you have any other questions or concerns.
||Occurring in more than 5% of people in the clinical trials.
Would you like to learn about Ig therapy that you can infuse yourself?
(Immune Globulin Subcutaneous
[Human] 20% Liquid)
Heritage of safety and
excellence
Receiving Privigen
therapy
The support
you need,
all in one place